Myelin basic protein

Therapeutic Solutions International Announces Antigen Specific Blockade of Pathological Immune Response in Multiple Sclerosis Model Using “Tattoo Gun” Immunization

Retrieved on: 
Wednesday, January 4, 2023

Previously other groups have used tattoo gun-based mechanisms to stimulate immune responses based on the theoretical advantage that a high number of microinjections results in a greater number of antigen presenting cells received to target immunogens.

Key Points: 
  • Previously other groups have used tattoo gun-based mechanisms to stimulate immune responses based on the theoretical advantage that a high number of microinjections results in a greater number of antigen presenting cells received to target immunogens.
  • “Utilizing a “tattoo gun” approach evokes a substantial degree of inflammation, which is classically believed to stimulate immunity.
  • “It would be extremely ironic if something as simple as a tattoo gun was the answer.”
    The concept of modulating antigen presentation to inhibit pathological immunity has previously been described.
  • However, the unexpected potency of the large surface area of injection only achievable by a tattoo gun was completely unexpected.

Global Neuroscience Antibodies and Assays Market 2020-2024 | Evolving Opportunities with Abcam Plc and Bio-Rad Laboratories Inc. | Technavio

Retrieved on: 
Thursday, February 27, 2020

The global neuroscience antibodies and assays market is poised to grow by USD 1.36 billion during 2020-2024, progressing at a CAGR of over 8% during the forecast period.

Key Points: 
  • The global neuroscience antibodies and assays market is poised to grow by USD 1.36 billion during 2020-2024, progressing at a CAGR of over 8% during the forecast period.
  • In addition, the advances in neuroscience instruments is anticipated to boost the growth of the neuroscience antibodies and assays market.
  • Major Five Neuroscience Antibodies and Assays Market Companies:
    Abcam Plc is headquartered in the UK and operates the business under the Sales of antibodies and related product segment.
  • The company offers Neuroscience development and repair antibodies, Neurodegeneration and Neurological Disease; Neuronal and Glial Markers; Neurotransmitters, receptors, and transporters; Myelin basic protein (MBP) antibodies, and F4/80 Antibodies.

MBP Solutions Marks 20 Years of Continued Business Growth with the Launch of an "Evolved", New Corporate Identity

Retrieved on: 
Friday, September 13, 2019

Today MBP Solutions has become a world leader in the collection, handling, processing, production and application of biological by-products and related services.

Key Points: 
  • Today MBP Solutions has become a world leader in the collection, handling, processing, production and application of biological by-products and related services.
  • The company today launched its updated corporate identity, developed to support its future growth plans - in particular increasing its sales and marketing activity.
  • The original MBP logotype has been refined and strengthened visually and an enhanced colour palette, reflecting MBP Solutions' core values (Professional, International, Innovative and Sustainable), has been added.
  • It's a simple, clean, strong, no-nonsense piece of design that very much reflects MBP Solutions as a business.